Arbutus Biopharma Corp

ABUS PE Ratio & Price to Earnings Analysis

Live trailing and forward price-to-earnings multiples for ABUS, with earnings yield, PEG ratio, historical P/E context and how today's multiple compares to what ABUS has traded at in the past.

$4.05+0.25% todayUSD · live quote
★ ZCoreAI PREMIUM7 days free

Start Your 7-Day ABUS Premium Trial

Explore the complete ABUS setup with live Z-Score, Smart Money signals, multi-timeframe analysis and premium indicators.

✓Z-Score signals
✓Smart Money flow
✓All timeframes
✓Premium indicators
Start 7-Day Free Trial →

7-day free trial. No commitment during the trial.

ABUS P/E Ratio Today

A trailing P/E ratio for ABUS is unavailable — trailing earnings are negative or not reported.

Forward P/E
—
EPS (TTM)
—
Earnings yield
—
PEG ratio
—

ABUS PE Ratio History

Reported price-to-earnings multiple for ABUS across recent periods, showing whether today's valuation is rich or cheap versus its own track record.

Historical P/E series for ABUS is not available from public filings right now.

ABUS Earnings & Fundamentals Behind the P/E

The earnings power and growth profile that justify — or fail to justify — the ABUS multiple.

Market cap
$620.84M
Revenue (TTM)
—
Revenue growth
—
EPS growth
—
Net margin
—
P/E (TTM)
—
Forward P/E
—
PEG ratio
—

ABUS Valuation & Statistical Context

See how the current valuation compares with historical multiples and earnings growth.

Z-Score readings for ABUS are not available right now.

How the ABUS P/E Ratio Is Calculated

The trailing P/E divides the live ABUS share price by trailing twelve-month diluted earnings per share. The forward P/E uses consensus estimated earnings for the next twelve months. Earnings yield is simply the inverse of the trailing P/E, expressed as a percentage, which makes it directly comparable to a bond yield. The PEG ratio divides the trailing P/E by the trailing-twelve-month (annual) EPS growth rate to adjust the multiple for growth. A single-quarter earnings jump is deliberately excluded, since it would understate the ratio.

Multiples are only meaningful in context. A P/E is best compared to the company's own history, to sector peers with similar margins, and to the growth actually being delivered. Nothing on this page is investment advice.

ABUS PE Ratio FAQ

What is the PE ratio of ABUS?

A trailing P/E for ABUS cannot be computed right now, typically because trailing earnings are negative or not yet reported.

Is ABUS overvalued based on its P/E?

Without a reliable historical P/E series for ABUS, compare the current multiple to sector peers and to the growth rate the company is delivering.

What is a good PE ratio?

There is no universal number. Mature, slow-growing businesses often trade in the low teens, while fast compounders can sustain multiples several times higher. What matters is whether earnings growth justifies the multiple — that is exactly what the PEG ratio measures.

What is the difference between trailing and forward P/E for ABUS?

Trailing P/E uses the last twelve months of reported earnings; forward P/E uses estimates for the coming year. Forward estimates for ABUS are not currently available.

Where does ZCoreAI get ABUS earnings data?

Quotes, earnings and fundamentals come from live ZCoreAI market endpoints and are refreshed on every page load, so the multiple you see reflects the latest reported figures and current price.

ABUS earnings

Quarterly EPS, revenue, net income and growth for ABUS.

ABUS forecast

DCF fair value, price prediction and signal targets for ABUS.

ABUS overview

Live chart, fundamentals and valuation context for ABUS.

ABUS dividends

Payout history, yield and dividend growth for ABUS.

Data refreshed from live ZCoreAI market endpoints. Informational only — not investment advice.